The Association of Clinical Research Organizations (ACRO) is lead by a distinguished team of business, drug development and technology experts that comprise ACRO’s Board of Directors. Our Board of Directors is dedicated to advocating on behalf of safe, ethical clinical trials that protect patients and ensure high-quality results.
All Regular ACRO members maintain a seat on our Board of Directors. In addition, our Board’s Executive Committee is made up of the current ACRO Chair, Vice-Chair, and the immediate Past-Chair.
Board of Directors
Steve Cutler
ACRO Chair & CEO, ICON
Jackie Kent
ACRO Vice-Chair and EVP & Head of Product, Medidata Solutions
Alistair Macdonald
Previous ACRO Chair & CEO, Syneos Health
Cynthia Verst
President Clinical Operations, IQVIA
Suresh Katta
Chief Executive Officer, Saama Technologies
David Coman
Chief Executive Officer, Science37
Henry Mcnamara
SVP & GM, Oracle Health Sciences
Roger Smith
CEO, Signant Health
Paul Kirchgraber
CEO, Covance Drug Development
Peyton Howell
Chief Commercial and Strategy Officer, Parexel
David Johnston
Executive Vice President of Global Clinical Development, PPD
Euan Menzies
CEO, Bioclinica
Joe Eazor
President & CEO, ERT
Henry Levy
General Manager, Veeva
Become and ACRO Member and add your voice.
ACRO Staff
Working together with ACRO’s member companies, our staff is committed to leveraging their collective experience in public policy, clinical research, communications and government relations to advance ACRO’s mission on behalf of our industry.
Doug Peddicord
Executive Director
Karen Noonan
Senior Vice President, Global Regulatory Policy
Anina Adelfio
Vice President, Industry Relations
Sophia McLeod
Director of Government Relations